Patrik joined Sitryx as Head of Biology in April 2019 from UCB where he was Head of Immuno-Bone Discovery, responsible for small molecule and antibody projects from target identification to candidate nomination. Previously, he was managing molecular and cellular biology, primary pharmacology and screening in a range of disease areas including immunology, bone and neurology. Patrik has more than 15 years experience in drug discovery and development. He has lead several large and small molecule drug discovery programs targeting a number of disease indications and with a number of external partners. Patrik was instrumental in several Public Private Partnerships (IMI, Neuroallianz).
Patrik has a diploma in biology and received a PhD in molecular biology from EMBL Heidelberg and has published over two dozen peer-reviewed publications.